BACKGROUND: We conducted a prospective cohort study to assess the acceptability, feasibility and safety of day-case laparoscopic fundoplication for gastroesophageal reflux disease in an university-based tertiary care center. METHODS: The procedure was proposed as routine for patients with proven symptomatic uncomplicated gastroesophageal reflux disease fulfilling predetermined inclusion criteria from September 2003 to December 2005. Standard anesthetic, surgical, analgesic, and antiemetic protocols were used. Acceptability, admission, complication, and reoperation rates and patient satisfaction were evaluated. Postoperative pain and nausea were assessed using an 11-point numeric rating scale (NRS). The Gastrointestinal Quality of Life Index (GIQLI) was administered before and after surgery. RESULTS: Among 100 patients screened, 40 (40%) were included. Seven patients were admitted because of inadequate pain control (n = 3), nausea or vomiting (n = 3), or anxiety (n = 1); 33 were discharged as planned 6 to 8 hours after operation. Only 1 patient was readmitted and reoperated because of fundoplicature migration following uncontrolled vomiting. At follow-up, 92.5% of patients were satisfied with the day-case treatment. If offered a similar operation in the future, 82.5% of patients would have accepted day-case treatment. The Gastrointestinal Quality of Life Index was 90.7 (+/-21.2) preoperatively compared with 105.8 (+/-21.8) postoperatively (P < .001). CONCLUSIONS: Day-case laparoscopic fundoplication is feasible in selected patients. However, (1) strict control of postoperative nausea and pain is essential, and (2) preoperative standardized education program for ambulatory surgery might be useful in order to enhance patient acceptability and satisfaction rates.
BACKGROUND: We conducted a prospective cohort study to assess the acceptability, feasibility and safety of day-case laparoscopic fundoplication for gastroesophageal reflux disease in an university-based tertiary care center. METHODS: The procedure was proposed as routine for patients with proven symptomatic uncomplicated gastroesophageal reflux disease fulfilling predetermined inclusion criteria from September 2003 to December 2005. Standard anesthetic, surgical, analgesic, and antiemetic protocols were used. Acceptability, admission, complication, and reoperation rates and patient satisfaction were evaluated. Postoperative pain and nausea were assessed using an 11-point numeric rating scale (NRS). The Gastrointestinal Quality of Life Index (GIQLI) was administered before and after surgery. RESULTS: Among 100 patients screened, 40 (40%) were included. Seven patients were admitted because of inadequate pain control (n = 3), nausea or vomiting (n = 3), or anxiety (n = 1); 33 were discharged as planned 6 to 8 hours after operation. Only 1 patient was readmitted and reoperated because of fundoplicature migration following uncontrolled vomiting. At follow-up, 92.5% of patients were satisfied with the day-case treatment. If offered a similar operation in the future, 82.5% of patients would have accepted day-case treatment. The Gastrointestinal Quality of Life Index was 90.7 (+/-21.2) preoperatively compared with 105.8 (+/-21.8) postoperatively (P < .001). CONCLUSIONS: Day-case laparoscopic fundoplication is feasible in selected patients. However, (1) strict control of postoperative nausea and pain is essential, and (2) preoperative standardized education program for ambulatory surgery might be useful in order to enhance patient acceptability and satisfaction rates.
Authors: Juan Carlos Molina; Ana María Misariu; Ioana Nicolau; Jonathan Spicer; David Mulder; Lorenzo E Ferri; Carmen L Mueller Journal: Surg Endosc Date: 2017-08-04 Impact factor: 4.584
Authors: César P Ramírez-Plaza; José L Gallego Perales; Naiara Marín Camero; Alberto Rodríguez-Cañete; José A Bondía-Navarro; Julio Santoyo-Santoyo Journal: Surg Endosc Date: 2011-02-27 Impact factor: 4.584
Authors: Swee H Teh; Samuel C Schecter; Edgar B Servais; Kingsway Liu; Jonathan Svahn; Lisa Yang; Monica Goodstein; Richard Parent; Edward Chau; Lynn Chang; Minhoa Zhou; Sharon Shiraga; Michelle Knox Journal: JAMA Surg Date: 2022-09-14 Impact factor: 16.681
Authors: C Gronnier; A Desbeaux; G Piessen; J Boutillier; N Ruolt; J P Triboulet; C Mariette Journal: Surg Endosc Date: 2014-02-12 Impact factor: 4.584
Authors: Malaika S Vlug; Jan Wind; Jan H Eshuis; Robert Lindeboom; Mark I van Berge Henegouwen; Willem A Bemelman Journal: Surg Endosc Date: 2009-01-01 Impact factor: 4.584
Authors: Tarik K Yuce; Ryan J Ellis; Ryan P Merkow; Nathaniel J Soper; Karl Y Bilimoria; David D Odell Journal: Surg Endosc Date: 2019-08-06 Impact factor: 4.584